以收入和形象问题为驱动力, 华盛顿市男性使用毛发损失药的比率最高, 尽管保险通常不覆盖关键治疗。 Washington D.C. has the highest U.S. rate of men using hair-loss meds, driven by income and image concerns, though insurance often doesn’t cover key treatments.

一项新的分析显示,华盛顿市男子填写理发药品处方的比率最高,是全国平均数的五倍以上,其次是马萨诸塞州、纽约州和加利福尼亚州,而西弗吉尼亚州、密西西比州和北达科他州的比例最低。 A new analysis shows Washington D.C. has the highest rate of men filling prescriptions for hair-loss medications—over five times the national average—followed by Massachusetts, New York, and California, while West Virginia, Mississippi, and North Dakota have the lowest rates. 高收入城市地区在使用方面处于领先地位,这很可能是由于对专业外观的关切。 Higher-income urban areas lead in usage, likely due to professional appearance concerns. 费纳斯特和普罗佩西亚是FDA批准的最常用药,但保险覆盖范围很大:商业计划覆盖大约70%的患者的仿制费纳斯特,但品牌Propecia和口服米诺克西迪尔通常被排除在外,特别是在医疗保险和医疗补助计划的受益者. Finasteride and Propecia are the most prescribed FDA-approved treatments, but insurance coverage varies widely: commercial plans cover generic finasteride for about 70% of patients, but brand-name Propecia and oral minoxidil are often excluded, especially for Medicare and Medicaid recipients. 男性秃头影响5 000多万美国男子,与遗传学、荷尔蒙、年龄和潜在的健康风险有关。 Male-pattern baldness affects over 50 million U.S. men and is linked to genetics, hormones, age, and potential health risks.